Evidence map›Paper›PMID 42819625›Full record

ArticleHSOA journal of alternative, complementary & integrative medicine2024

Cytoprotection against Cadmium by Nrf2-Activating Dietary Phytochemicals.

Brooks M Hybertson, Bifeng Gao, Swapan Bose, Joe M McCord

Abstract read
In one paragraph

Article in HSOA journal of alternative, complementary & integrative medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Brooks M HybertsonPathways Bioscience, Aurora, USA.
Bifeng GaoPathways Bioscience, Aurora, USA.
Swapan BosePathways Bioscience, Aurora, USA.
Joe M McCordPathways Bioscience, Aurora, USA.

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Supporting Healthy Aging with a Phytochemical Combination that Acts at Multiple Control Points in the Nrf2 Activation PathwayR43AG053128 · NIA · PATHWAYS BIOSCIENCE, LLC · PI HYBERTSON, BROOKS MICHAEL · 2017 to 2017
$210k
NCI NIH HHS P30 CA046934NIA NIH HHS R43 AG053128
6 · The paper itself

Abstract

Background: Environmental exposure to toxic heavy metals such as cadmium continues to cause significant human health impacts around the world. Objective: This aim of this study was to determine potential benefits of a Nrf2 activating phytochemical combination against cadmium-induced cytotoxicity. Methods: Human Hepatocellular Carcinoma (HepG2) cells were treated with the Nrf2-activating PB123 combination of dietary phytochemicals and the cultured HepG2 cells were challenged with cadmium (CdSO4). Cytotoxicity effects were evaluated by assays of cell viability (CCK8 assay) and cell injury (LDH release assay). Gene mRNA expression in PB123-treated cells was determined by RNA-seq. Results: PB123 upregulated metallothionein gene expression in the HepG2 cells, and pretreatment with PB123 protected HepG2 cells from Cd2+ toxicity measured both as cell viability (CCK8 assay) and cell injury (LDH release assay). Use of the Nrf2-inhibitor AEM1 suggested a Nrf2-dependence of the PB123-induced protection. Transcriptomic analyses of gene expression data from PB123-treated cells revealed both Nrf2-related and metallothionein-related pathways as key Reactome findings, and Detoxification as a primary Gene Ontology endpoint. Conclusion: In context with previous work by others, the present findings indicate that rosemary-based dietary supplement products like PB123 might promote beneficial responses against environmental cadmium exposure.

Indexed as

AgingCadmiumKEAP1MetallothioneinNrf2

Identifiers

PMID42819625
PMCPMC13626554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.